Avantor Management
Management criteria checks 1/4
Avantor's CEO is Emmanuel Ligner, appointed in Aug 2025, has a tenure of less than a year. total yearly compensation is $5.90M, comprised of 6.4% salary and 93.6% bonuses, including company stock and options. directly owns 0.013% of the company’s shares, worth €733.46K. The average tenure of the management team and the board of directors is 2.3 years and 2.8 years respectively.
Key information
Emmanuel Ligner
Chief executive officer
US$5.9m
Total compensation
| CEO salary percentage | 6.43% |
| CEO tenure | less than a year |
| CEO ownership | 0.01% |
| Management average tenure | 2.3yrs |
| Board average tenure | 2.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | -US$551m |
| Dec 31 2025 | US$6m | US$379k | -US$530m |
Compensation vs Market: Emmanuel's total compensation ($USD5.90M) is above average for companies of similar size in the German market ($USD2.60M).
Compensation vs Earnings: Insufficient data to compare Emmanuel's compensation with company performance.
CEO
Emmanuel Ligner (55 yo)
Mr. Emmanuel Ligner is President and Chief Executive Officer of Avantor, Inc. from August 18, 2025 and serves as its Director. He was Chief Executive Officer of Cerba HealthCare S.A.S. from March 01, 2024...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | less than a year | US$5.90m | 0.013% € 733.5k | |
| Executive VP | 2.9yrs | US$3.75m | 0.0033% € 190.5k | |
| President of Laboratory Solutions | 2yrs | US$5.99m | 0.0024% € 134.4k | |
| Executive Vice President of Bioscience Production | 2.7yrs | US$5.23m | 0.0036% € 208.3k | |
| Senior VP | 7.1yrs | no data | 0.019% € 1.1m | |
| Executive VP & COO | less than a year | no data | no data | |
| Executive VP & Chief Information Officer | 8.2yrs | US$3.19m | no data | |
| Vice President of Investor Relations | less than a year | no data | no data | |
| Executive VP & Chief Human Resources Officer | 2.8yrs | no data | 0.036% € 2.1m | |
| Executive Vice President of AMEA | 8.2yrs | no data | 0.0088% € 501.8k | |
| EVP of Bioscience & Medtech Products and Chief Transformation Officer | less than a year | no data | no data | |
| Executive Vice President of Quality & Regulatory | less than a year | no data | no data |
Experienced Management: AVG's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | no data | US$5.90m | 0.013% € 733.5k | |
| Independent Chairman of the Board | 6.1yrs | US$329.99k | 0.065% € 3.7m | |
| Independent Director | less than a year | US$151.26k | 0.0088% € 502.9k | |
| Independent Director | 1.6yrs | US$332.58k | 0.00070% € 40.0k | |
| Independent Director | 4.6yrs | US$329.99k | 0.0051% € 293.5k | |
| Chair of Scientific Advisory Board | 2.8yrs | US$3.09m | no data | |
| Independent Director | 6.2yrs | US$324.99k | 0.0064% € 363.9k | |
| Member of Scientific Advisory Board | 2.8yrs | no data | no data | |
| Independent Director | 4.7yrs | US$317.49k | 0.0040% € 227.1k | |
| Member of Scientific Advisory Board | 2.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.8yrs | no data | no data | |
| Member of Scientific Advisory Board | 2.4yrs | no data | no data |
Experienced Board: AVG's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/22 12:01 |
| End of Day Share Price | 2026/06/22 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Avantor, Inc. is covered by 26 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Catherine Ramsey Schulte | Baird |
| Luke Sergott | Barclays |
| Michael Ryskin | BofA Global Research |